KKM lapor 383 kes baharu Covid-19, 8 kematian | The Malaysian Insight

Malaysia News News

KKM lapor 383 kes baharu Covid-19, 8 kematian | The Malaysian Insight
Malaysia Latest News,Malaysia Headlines
  • 📰 msianinsight
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

KKM lapor 383 kes baharu Covid-19, 8 kematian

Jumlah keseluruhan jangkitan Covid-19dalam negara kini mencecah 5,030,696 kes, menurut KKM. – Gambar fail The Malaysian Insight, 10 Januari 2023.

SEBANYAK 383 kes baharu Covid-19 direkodkan semalam, menjadikan jumlah keseluruhan jangkitan dalam negara kini mencecah 5,030,696 kes, menurut Kementerian Kesihatan . Kes aktif Covid-19 turun kepada 11,414 selepas 355 kes pulih dicatat, menurut data di laman web KKMNow. Bermula July 2018, akses bagi laporan penuh hanya untuk anda yang melanggan. Daftar sekarang dan nikmati satu minggu akses percuma!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

msianinsight /  🏆 8. in MY

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Covid-19 Watch: 383 new cases, says Health MinistryCovid-19 Watch: 383 new cases, says Health MinistryPETALING JAYA: Malaysia recorded 383 new Covid-19 infections on Monday (Jan 9), says the Health Ministry.
Read more »

Germany, Belgium, Luxembourg discourage travel to Covid-hit ChinaGermany, Belgium, Luxembourg discourage travel to Covid-hit ChinaBERLIN: Germany, Belgium and Luxembourg on Saturday discouraged non-essential trips to China, the world&039;s most populous nation, as it struggles with a...
Read more »

Dr Sim encourages Sarawakians who took Chinese Covid vaccines to take Pfizer-BioNTech booster shotsDr Sim encourages Sarawakians who took Chinese Covid vaccines to take Pfizer-BioNTech booster shotsKUCHING, Jan 8 — Sarawakians who have been administered Covid-19 vaccines made in China for their first and second doses are advised to take Pfizer-BioNTech for their subsequent...
Read more »



Render Time: 2025-02-28 10:28:53